期刊文献+

HPLC-MS/MS法测定人血浆中灯盏乙素的浓度 被引量:2

Determination of scutellarin in human plasma by HPLC-MS/MS
原文传递
导出
摘要 目的:建立测定人血浆中灯盏乙素浓度的HPLC-MS/MS法。方法:采用Platisil ODS色谱柱(250 mm×4.6 mm,5μm),流动相为0.3%甲酸水溶液-甲醇(40∶60),流速为1.0 mL.min-1,以黄芩苷为内标,经乙酸乙酯萃取后,采用电喷雾电离化(ESI)方式和多反应离子监测(MRM)模式进行负离子检测,用于定量分析离子反应分别为m/z 461.1→285.1(灯盏乙素)和m/z 445.1→269.1(黄芩苷)。结果:线性检测范围为0.20~50.00μg.L-1,最低定量浓度0.20μg.L-1,r=0.999 3。低、中、高3个浓度的提取回收率分别为63.5%,69.5%,66.8%,基质效应分别为105.7%,97.5%,96.5%。结论:本法样品处理简单、快速,专属性强,灵敏度高,可用于灯盏乙素在人体内的药代动力学研究。 Objective: To establish an HPLC-MS/MS method for the determination of scutellarin in human plasma. Methods: Scutellarin and an interal standard were separated on a Platisil ODS column (250mm×4.6mm,5μm) ; The mobile phase was consisted of 0.3% formic acid-methanol (40: 60) at a flow rate of 1.0 mL·min^-1. The drug and an internal standard (baicalin) were extracted from plasma with ethyl acetate. A mass spectrometer equipped with electrospray ionization source was used as detector operated in the negative ion mode. A multiple reaction monitoring (MRM) mode using the transition of m/z 461.1→285.1 and m/z 445.1→269.1 was used to quantify scutellarin and interal standard, respectively. Results : The linear range of scutellarin was 0.20 50.00 μg·L^-1, and the minimum detective concentration was 0.20 μg·L^-1, r = 0. 999 3. The extraction recoveries of the three concentrations were 63.5% , 69.5% and 66.8% , and the matrix effects were 105.7% , 97.5% and 96.5% , respectively. Conclusion: The method is sensitive, rapid, convenient, and is proven to be possible for investigation of scutellarin in human plasma.
出处 《中国新药杂志》 CAS CSCD 北大核心 2011年第19期1903-1906,共4页 Chinese Journal of New Drugs
关键词 灯盏乙素 血药浓度 HPLC-MS/MS scutellarin drug plasma concentration HPLC-MS/MS
  • 相关文献

参考文献7

二级参考文献22

  • 1蒋学华,李素华,兰轲,杨俊毅,周静.灯盏花素在家犬体内的药代动力学[J].药学学报,2003,38(5):371-373. 被引量:67
  • 2居文政,张军,谈恒山,蒋萌,陈玟,熊宁宁.高效液相质谱联用法(HPLC-MS)测定灯盏乙素血药浓度及其临床药代动力学研究[J].中国临床药理学与治疗学,2005,10(3):298-301. 被引量:30
  • 3刘奕明,林爱华,陈汇,曾繁典.灯盏花素在小鼠体内药物动力学研究[J].中国临床药理学与治疗学,2005,10(3):310-313. 被引量:18
  • 4[1]Chen XQ, Jin YY. The New Edition of Medicaments (新编药物学) [M]. 14th Ed. Beijing: People's Medical Publishing House, 1997.277-278.
  • 5[2]Xu QY, Li XX. Influences of Dengzhan Xixin injection on blood viscosity in patients with high blood viscosity [J]. Chin J New Drugs Clin Rem(中国新药与临床杂志), 1995,14(4):233-235.
  • 6[3]Xu JM, Huang ZH. DengZhan XiXin capsules in the treatment of cerebrovascular disorders in 74 patients [J]. Chin J New Drugs Clin Rem(中国新药与临床杂志), 1991,10(5):260-263.
  • 7[4]Department of Chinese Tradititional Medicine and Herbal Drugs, State Drug Administration. Handbook of Active Ingredients of Phytomedicines (植物药有效成分手册) [Z]. Beijing: People's Medical Publishing House, 1986.946-947.
  • 8陈新谦 金有豫.新编药物学[M](第14版)[M].北京:人民卫生出版社,1997.285.
  • 9许禄,化学计量学方法,1995年
  • 10萧参,中国药学杂志,1993年,28卷,425页

共引文献741

同被引文献31

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部